Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1997-4-11
|
pubmed:abstractText |
Treatment results and prognostic variables were studied in 549 adult patients with Hodgkin's disease after first-line and salvage treatment. After first-line treatment, 479 out of 549 patients (87%) achieved complete remission (CR). During a mean observation time of 74 months, 99 patients (21%) relapsed. Sixty-nine patients (70% of relapsed patients) achieved a second CR. Variables predicting poor response (< CR) and shortened survival after first-line treatment were advanced disease, B-symptoms and age >60 years. In relapsing patients, age >60 years, relapse within 12 months and non-CR after relapse treatment predicted a poor prognosis, and none of these patients were alive after 10 years. Localized disease at diagnosis and relapse, and relapse later than 24 months predicted a good prognosis with 10-year survival after relapse of 68% and 57%, respectively. Patients with a second relapse had 5-year survival of 28% and 10-year survival of 14%. Based on the prognostic variables at first-line treatment and at relapse, selection of patients to more intensive treatment is discussed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0284-186X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35 Suppl 8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
67-72
|
pubmed:dateRevised |
2009-5-12
|
pubmed:meshHeading |
pubmed-meshheading:9073050-Adolescent,
pubmed-meshheading:9073050-Adult,
pubmed-meshheading:9073050-Age Factors,
pubmed-meshheading:9073050-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9073050-Female,
pubmed-meshheading:9073050-Hodgkin Disease,
pubmed-meshheading:9073050-Humans,
pubmed-meshheading:9073050-Male,
pubmed-meshheading:9073050-Middle Aged,
pubmed-meshheading:9073050-Neoplasm Recurrence, Local,
pubmed-meshheading:9073050-Prognosis,
pubmed-meshheading:9073050-Radiotherapy, Adjuvant,
pubmed-meshheading:9073050-Retrospective Studies,
pubmed-meshheading:9073050-Salvage Therapy,
pubmed-meshheading:9073050-Survival Analysis,
pubmed-meshheading:9073050-Time Factors,
pubmed-meshheading:9073050-Treatment Outcome
|
pubmed:year |
1996
|
pubmed:articleTitle |
Prognostic variables and results of salvage treatment in Hodgkin's disease.
|
pubmed:affiliation |
Department of Oncology, The Norwegian Radium Hospital, Oslo.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|